Literature DB >> 34349537

Estimation of the Prevalence of Nonalcoholic Fatty Liver Disease in an Adult Population in Northern China Using the Data Mining Approach.

TengFei Yang1, Bo Zhao2, Dongmei Pei1.   

Abstract

BACKGROUND: Nonalcoholic fatty liver disease (NAFLD) is the commonest form of chronic liver disease worldwide and its prevalence is rapidly increasing. Screening and early diagnosis of high-risk groups are important for the prevention and treatment of NAFLD; however, traditional imaging examinations are expensive and difficult to perform on a large scale. This study aimed to develop a simple and reliable predictive model based on the risk factors for NAFLD using a decision tree algorithm for the diagnosis of NAFLD and reduction of healthcare costs.
METHODS: This retrospective cross-sectional study included 22,819 participants who underwent annual health examinations between January 2019 and December 2019 at Physical Examination Center in Shengjing Hospital of China Medical University. After rigorous data screening, data of 9190 participants were retained in the final dataset for use in the J48 decision tree algorithm for the construction of predictive models. Approximately 66% of these patients (n=6065) were randomly assigned to the training dataset for the construction of the decision tree, while 34% of the patients (n=3125) were assigned to the test dataset to evaluate the performance of the decision tree.
RESULTS: The results showed that the J48 decision tree classifier exhibited good performance (accuracy=0.830, precision=0.837, recall=0.830, F-measure=0.830, and area under the curve=0.905). The decision tree structure revealed waist circumference as the most significant attribute, followed by triglyceride levels, systolic blood pressure, sex, age, and total cholesterol level.
CONCLUSION: Our study suggests that a decision tree analysis can be used to screen high-risk individuals for NAFLD. The key attributes in the tree structure can further contribute to the prevention of NAFLD by suggesting implementable targeted community interventions, which can help improve the outcome of NAFLD and reduce the burden on the healthcare system.
© 2021 Yang et al.

Entities:  

Keywords:  J48 algorithm; decision tree; nonalcoholic fatty liver disease; risk factors

Year:  2021        PMID: 34349537      PMCID: PMC8326527          DOI: 10.2147/DMSO.S320808

Source DB:  PubMed          Journal:  Diabetes Metab Syndr Obes        ISSN: 1178-7007            Impact factor:   3.168


  22 in total

Review 1.  Non-alcoholic fatty liver disease: a review of epidemiology, risk factors, diagnosis and management.

Authors:  Tony Dazhong Huang; Jason Behary; Amany Zekry
Journal:  Intern Med J       Date:  2020-09       Impact factor: 2.048

2.  Fatty liver disease: is it nonalcoholic fatty liver disease or obesity-associated fatty liver disease?

Authors:  Samir Softic; C Ronald Kahn
Journal:  Eur J Gastroenterol Hepatol       Date:  2019-01       Impact factor: 2.566

3.  Tuberculosis transmission in nontraditional settings: a decision-tree approach.

Authors:  J Steve Kammerer; Scott J N McNabb; Jose E Becerra; Lisa Rosenblum; Nong Shang; Michael F Iademarco; Thomas R Navin
Journal:  Am J Prev Med       Date:  2005-02       Impact factor: 5.043

Review 4.  Prevalence of fatty liver disease and the economy in China: A systematic review.

Authors:  Jin-Zhou Zhu; Qin-Yi Zhou; Yu-Ming Wang; Yi-Ning Dai; Jiang Zhu; Chao-Hui Yu; You-Ming Li
Journal:  World J Gastroenterol       Date:  2015-05-14       Impact factor: 5.742

5.  Prevalence and Risk Factors of Nonalcoholic Fatty Liver Disease and Advanced Fibrosis in General Population: the French Nationwide NASH-CO Study.

Authors:  Oumarou Nabi; Karine Lacombe; Jérôme Boursier; Philippe Mathurin; Marie Zins; Lawrence Serfaty
Journal:  Gastroenterology       Date:  2020-05-04       Impact factor: 22.682

6.  Development of chronic kidney disease in patients with non-alcoholic fatty liver disease: A cohort study.

Authors:  Dong Hyun Sinn; Danbee Kang; Hye Ryoun Jang; Seonhye Gu; Soo Jin Cho; Seung Woon Paik; Seungho Ryu; Yoosoo Chang; Mariana Lazo; Eliseo Guallar; Juhee Cho; Geum-Youn Gwak
Journal:  J Hepatol       Date:  2017-09-20       Impact factor: 25.083

Review 7.  Nonalcoholic fatty liver disease: a systematic review.

Authors:  Mary E Rinella
Journal:  JAMA       Date:  2015-06-09       Impact factor: 56.272

Review 8.  Data mining in healthcare and biomedicine: a survey of the literature.

Authors:  Illhoi Yoo; Patricia Alafaireet; Miroslav Marinov; Keila Pena-Hernandez; Rajitha Gopidi; Jia-Fu Chang; Lei Hua
Journal:  J Med Syst       Date:  2011-05-03       Impact factor: 4.460

Review 9.  Non-invasive assessment of non-alcoholic fatty liver disease: Clinical prediction rules and blood-based biomarkers.

Authors:  Eduardo Vilar-Gomez; Naga Chalasani
Journal:  J Hepatol       Date:  2017-12-02       Impact factor: 25.083

Review 10.  Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes.

Authors:  Zobair M Younossi; Aaron B Koenig; Dinan Abdelatif; Yousef Fazel; Linda Henry; Mark Wymer
Journal:  Hepatology       Date:  2016-02-22       Impact factor: 17.425

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.